|Tapering and discontinuing biologic DMARDs is conditionally recommended after inactive disease has been attained.|Very low|PICO 29. In patients with systemic JIA in clinical remission with biologic monotherapy, is tapering by decreasing dosage superior to tapering dosing interval at preventing disease exacerbation, preventing development of antidrug antibodies, and minimizing medication toxicity?|140â€“143|</p>